Sofinnova Investments, Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sofinnova Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$39.79 - $67.01 $4.97 Million - $8.37 Million	-124,952 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $949,541 - $1.47 Million	27,507 Added 28.23%	124,952 $6.43 Million
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $1.06 Million - $1.53 Million	-35,621 Reduced 26.77%	97,445 $3.6 Million
Q3 2018 Nov 15, 2018	BUY	$32.79 - $43.0 $4.36 Million - $5.72 Million	133,066 New	133,066 $5 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.